首页> 外文OA文献 >A randomized, double-blind, double-dummy, controlled, multicenter study of Qingzhong (tenofovir disoproxil fumarate) versus Viread for the treatment of chronic hepatitis B

【2h】

A randomized, double-blind, double-dummy, controlled, multicenter study of Qingzhong (tenofovir disoproxil fumarate) versus Viread for the treatment of chronic hepatitis B

机译：一种随机，双盲，双伪，对清虹（替诺福韦解毒型富马酸骨型）对慢性乙型肝炎的病毒（Tenofovir Disocroxil）的多中心研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Rong-Yue Liang; Jing-Hang Xu; Chong-Wen Si; Sa Wang; Jia Shang; Zu-Jiang Yu; Qing Mao; Qing Xie; Wei Zhao; Jun Li; Zhi-Liang Gao; Shan-Ming Wu; Hong Tang; Jun Cheng; Xin-Yue Chen; Wen-Hong Zhang; Hao Wang; Zhong-Nan Xu; Ling Wang; Jun Dai; Yan-Yan Yu;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A randomized double-blind comparison of coformulated elvitegravir/ cobicistat/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: Analysis of week 96 results [J] . ZolopaA., SaxP.E., DejesusE., JAIDS: Journal of acquired immune deficiency syndromes . 2013,第1期

机译：联合配制的依维格韦/ cobicistat /恩曲他滨/替诺福韦富马酸替诺福韦与依法韦仑/恩曲他滨/替诺福韦富马酸替莫韦特在HIV-1感染初始治疗中的随机双盲比较：分析第96周的结果
2. A randomized, double-blind, double-dummy, controlled, multicenter study of entecavir maleate versus entecavir for treatment of Chinese chronic hepatitis B predominantly genotype B or C: results at week 144 [J] . Xu Jinghang, Yu Yanyan, Si Chongwen, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2016,第S1期

机译：随机，双盲，双伪，控制，多中心研究Entecavir Maleate对恩替卡韦治疗中国慢性乙型肝炎，主要是基因型B或C：结果在第144周的结果
3. Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: A randomised, double-blind, phase 3, non-inferiority trial [J] . DeJesusE., RockstrohJ.K., HenryK., The Lancet . 2012,第9835期

机译：共同制定的Elvitegravir，Cobicistat，Emtricistabine和Tenofovir Disoproxil富马酸葡萄球菌与Ritonavir-Boosted Atazanavir加上共同制定的Emtricicabine和Tenofovir Disoproxil Mumarate用于初始治疗HIV-1感染：随机，双盲，第3期，非劣级试验
4. MULTI-CENTER, PLACEBO-CONTROLLED, DOUBLE-BLIND, RANDOMIZED STUDY OF ORAL TOCERANIB PHOSPHATE (PALLADIATM, SU11654), A RECEPTOR TYROSINE KINASE INHIBITOR, FOR THE TREATMENT OF DOGS WITH RECURRENT MAS [C] . Cheryl L London, Carolyn J Henry, Anthony W Rusk, Annual conference of the Veterinary Cancer Society . 2008

机译：多中心，安慰剂对照，双盲，随机研究口服Toceranib磷酸盐（Palladia TM，SU11654），受体酪氨酸激酶抑制剂，用于治疗经常性MAS的狗
5. Effect of whey protein quality on physiological response to chronic resistance exercise in trained men: A double-blind, placebo-controlled, randomized trial. [D] . Lockwood, Christopher M. 2010

机译：乳清蛋白质量对训练有素的男性对慢性抵抗运动的生理反应的影响：一项双盲，安慰剂对照，随机试验。
6. Tenofovir disoproxil fumarate in Chinese chronic hepatitis B patients: Results of a multicenter double-blind double-dummy clinical trial at 96 weeks [O] . Xiao-Fan Chen, Ya-Nan Fan, Chong-Wen Si, 2021

机译：Tenofovir Disoproxil Mumarate在中国慢性乙型肝炎患者：多中心双盲双伪临床试验在96周的结果
7. PGI15 Cost Effectiveness Analysis Of Tenofovir Disoproxil Fumarate (Viread®) In The Treatment Of Patients With Chronic Hepatitis B (Chb) In Mexico [O] . Soto H., Botello B.S., Pizarro M., 2013

机译：替诺福韦富马酸替诺福韦酯（Viread®）在墨西哥治疗慢性乙型肝炎（Chb）的成本效益分析

A randomized, double-blind, double-dummy, controlled, multicenter study of Qingzhong (tenofovir disoproxil fumarate) versus Viread for the treatment of chronic hepatitis B

著录项

引文网络

相似文献

相关主题

期刊订阅